Search results
Results from the WOW.Com Content Network
SIDP offers educational activities focusing on infectious diseases pharmacotherapy and antimicrobial stewardship through a variety of formats, including live and enduring webinar programming, home study materials, and live sessions at the annual SIDP business meeting, which is held concurrently with IDWeek. [31]
Effective January 1, 2020, the Joint Commission antimicrobial stewardship requirements were expanded to outpatient health care organizations as well. [21] In 2018, a survey of AMS programs in the US showed each 0.50 increase in pharmacist and physician full-time equivalent support predicted a roughly 1.5-fold increase in the programs effectiveness.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is a non-profit international organization with headquarters in Basel, Switzerland.An important activity of the society is the organization of the annual scientific congress ESCMID Global (formerly known as ECCMID).
Antimicrobial resistance is a critical global public health issue, and antimicrobial stewardship strategies are key to curtailing the problem. CIDRAP's Antimicrobial Stewardship Project provides current, accurate, and comprehensive information on the topic and works to build an online community to address leading issues.
Current BSAC activities include: Publishes the Journal of Antimicrobial Chemotherapy [5] and its sister publication, JAC-AMR. [6]Provides accreditation to hospitals as part of its Global Antimicrobial Stewardship Scheme (GAMSAS), [7] a programme of work that was used as a case study in the Government of the United Kingdom's National Action Plan on antimicrobial resistance, ‘Confronting ...
A review of investigational antibiotics shows that several new agents will become available in the coming years, even though the pace of antimicrobial research has proven far too slow. Overuse of antimicrobial agents and problems with infection control practices have led to the development of multidrug-resistant gram-negative bacterial infections.
It also aims to strengthen and enhance academic-industrial partnerships by bringing together communities that need antibiotics with academia, health-care professionals, and pharmaceutical companies to address the challenges facing antibiotic research, drug development, and Antimicrobial stewardship. [4]
A subsidiary aspect of infection control involves preventing the spread of antimicrobial-resistant organisms such as MRSA. This in turn connects to the discipline of antimicrobial stewardship —limiting the use of antimicrobials to necessary cases, as increased usage inevitably results in the selection and dissemination of resistant organisms.